Emerging Companies

Emerging Companies

Syntactx has the expertise needed to help Emerging Companies succeed and stay on the cutting-edge of medical technology. Whether running a full trial or providing individual services, we have the experience, technology, and processes to seamlessly manage a trial while maintaining a continuous, accurate, and transparent exchange of  information between clients and service teams.

Years of interactive experience with regulatory agencies worldwide allow us to help clients successfully navigate the regulatory pathways, while in-house physician specialists provide internal reviews of the clinical evidence we help produce. We offer services from strategy and protocol development to medical writing and post-market awareness. We can provide full-service clinical trial support that complements in-house competencies and helps achieve long-term strategic goals.

Our experience

Syntactx helps emerging companies leverage clinical studies with positive patient outcomes to make them attractive for an acquisition, IPO, or to grow market presence.

  • Helped to prime over a dozen clients for acquisition
  • Intervened and rescued several trials previously at-risk of failure
  • Our core lab intervened mid-study to address interobserver variability in image interpretation
  • Through evidence generation and data analyses, we’ve helped companies with at-risk devices keep CE mark/market approval


Stefaan Van der Meulen works with companies to establish a clinical presence internationally.


Discover Syncrony, our next generation EDC. Syncrony is a cutting-edge tool that combines data capture, reporting, analytics, and statistics, and has been proven to increase the accuracy in collecting, tracking, and storing clinical trial data.

Discover how Syncrony can support you.